이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Standard Chemical & Pharmaceutical 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Tzu-Ting Fan

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	16yrs
CEO 소유권	6.6%
경영진 평균 재임 기간	1.3yrs
이사회 평균 재임 기간	2yrs

최근 관리 업데이트

Recent updates

If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

Apr 13

Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 19

Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Jan 04

Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

Dec 22

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Dec 08

Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Nov 26

CEO

Tzu-Ting Fan

16yrs

테뉴어

Mr. Tzu-Ting Fan serves as General Manager and Director of Standard Chem. & Pharm. Co., Ltd.and its President since July 1, 2008. He serves as Representative of Corporate Director of Syn-Tech Chem. & Phar...

리더십 팀

이름	위치	테뉴어	보상	소유권
Tzu-Ting Fan	President	16yrs	데이터 없음	6.58% NT$ 881.3m
Chin Wen Chang	Financial Officer	1.3yrs	데이터 없음	데이터 없음
Chin-Tsai Fan	GM & Director	1.3yrs	데이터 없음	데이터 없음

1.3yrs

평균 재임 기간

경험이 풍부한 관리: 1720 의 관리팀은 경험 (평균 재직 기간 1.3 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Tzu-Ting Fan	President	no data	데이터 없음	6.58% NT$ 881.3m
Chin-Tsai Fan	GM & Director	no data	데이터 없음	데이터 없음
Yuan-Teh Lee	Director	no data	데이터 없음	데이터 없음
Wen-Chang Lin	Additional Director	1.1yrs	데이터 없음	0.052% NT$ 7.0m
Hwei-Jiung Wang	Independent Director	no data	데이터 없음	데이터 없음
Lin-Yu Lee	Independent Director	no data	데이터 없음	0.017% NT$ 2.2m
Tsuey-Wen Yeh	Director	3.5yrs	데이터 없음	데이터 없음
Shaw-Tzong Liu	Independent Director	2.9yrs	데이터 없음	데이터 없음
Lawrence C. Lee	Additional Independent Director	1.1yrs	데이터 없음	데이터 없음

2.0yrs

평균 재임 기간

경험이 풍부한 이사회: 1720 의 이사회는 경험(평균 재직 기간 1.9 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Standard Chemical & Pharmaceutical 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Standard Chemical & Pharmaceutical Co. Ltd., Annual General Meeting, Jun 20, 2024

Standard Chemical & Pharmaceutical Co. Ltd. Elects One Additional Director and One Additional Independent Director

Less than half of directors are independent

Less than half of directors are independent

Standard Chem & Pharm CO., LTD., Annual General Meeting, Jun 21, 2022

Less than half of directors are independent

Recent updates

First quarter 2024 earnings released: EPS: NT$1.41 (vs NT$1.18 in 1Q 2023)

Standard Chemical & Pharmaceutical Co. Ltd. to Report Q1, 2024 Results on May 07, 2024

Full year 2023 earnings released: EPS: NT$4.67 (vs NT$4.56 in FY 2022)

Standard Chemical & Pharmaceutical Co. Ltd., Annual General Meeting, Jun 20, 2024

Now 20% overvalued after recent price rise

Now 20% overvalued after recent price rise

Now 21% overvalued after recent price rise

Third quarter 2023 earnings released: EPS: NT$1.25 (vs NT$1.34 in 3Q 2022)

Second quarter 2023 earnings released: EPS: NT$1.33 (vs NT$1.28 in 2Q 2022)

Upcoming dividend of NT$2.50 per share at 3.8% yield

Standard Chemical & Pharmaceutical Co. Ltd. Elects One Additional Director and One Additional Independent Director

Investor sentiment improves as stock rises 22%

Full year 2022 earnings released: EPS: NT$4.56 (vs NT$3.96 in FY 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: NT$1.34 (vs NT$0.89 in 3Q 2021)

Now 20% undervalued

Now 20% undervalued

Second quarter 2022 earnings released: EPS: NT$1.28 (vs NT$0.93 in 2Q 2021)

Upcoming dividend of NT$2.50 per share

First quarter 2022 earnings released: EPS: NT$0.97 (vs NT$1.17 in 1Q 2021)

Less than half of directors are independent

Standard Chem & Pharm CO., LTD., Annual General Meeting, Jun 21, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS NT$0.89 (vs NT$0.64 in 3Q 2020)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Second quarter 2021 earnings released: EPS NT$0.93 (vs NT$0.73 in 2Q 2020)

Upcoming dividend of NT$1.80 per share

First quarter 2021 earnings released: EPS NT$1.17 (vs NT$0.67 in 1Q 2020)

If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

SYN-TECH Chem. & Pharm. Co., Ltd. (GTSM:1777) agreed to acquire API synthesis department of Standard Chemical from Standard Chem & Pharm CO., LTD. (TSEC:1720) for TWD 341 million.

Full year 2020 earnings released: EPS NT$2.93 (vs NT$2.11 in FY 2019)

Standard Chem & Pharm CO., LTD., Annual General Meeting, Jun 18, 2021

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

New 90-day low: NT$35.20

Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

New 90-day low: NT$36.50

Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Third quarter 2020 earnings released: EPS NT$0.64

New 90-day low: NT$37.55

New 90-day low: NT$37.70

New 90-day low - NT$38.30

First half earnings released

CEO

테뉴어

리더십 팀

평균 재임 기간

이사회 구성원

평균 재임 기간